Zobrazeno 1 - 10
of 235
pro vyhledávání: '"Michael S, Rogers"'
Autor:
Telma Saraiva-Santos, Tiago H. Zaninelli, Marília F. Manchope, Ketlem C. Andrade, Camila R. Ferraz, Mariana M. Bertozzi, Nayara A. Artero, Anelise Franciosi, Stephanie Badaro-Garcia, Larissa Staurengo-Ferrari, Sergio M. Borghi, Graziela S. Ceravolo, Avacir Casanova Andrello, Janaína Menezes Zanoveli, Michael S. Rogers, Rubia Casagrande, Felipe A. Pinho-Ribeiro, Waldiceu A. Verri
Publikováno v:
Frontiers in Immunology, Vol 14 (2023)
BackgroundLipoxin A4 (LXA4) has anti-inflammatory and pro-resolutive roles in inflammation. We evaluated the effects and mechanisms of action of LXA4 in titanium dioxide (TiO2) arthritis, a model of prosthesis-induced joint inflammation and pain.Meth
Externí odkaz:
https://doaj.org/article/bcd1d34c704c4929903bb0223edab626
Autor:
Debra Van Egeren, Alexander Novokhodko, Madison Stoddard, Uyen Tran, Bruce Zetter, Michael S. Rogers, Diane Joseph-McCarthy, Arijit Chakravarty
Publikováno v:
Scientific Reports, Vol 11, Iss 1, Pp 1-9 (2021)
Abstract The rapid emergence and expansion of novel SARS-CoV-2 variants threatens our ability to achieve herd immunity for COVID-19. These novel SARS-CoV-2 variants often harbor multiple point mutations, conferring one or more evolutionarily advantag
Externí odkaz:
https://doaj.org/article/1e588587b1a248438243cf75bb3474be
Autor:
Debra Van Egeren, Madison Stoddard, Laura F. White, Natasha S. Hochberg, Michael S. Rogers, Bruce Zetter, Diane Joseph-McCarthy, Arijit Chakravarty
Publikováno v:
Vaccines, Vol 11, Iss 4, p 853 (2023)
The rapid emergence of immune-evading viral variants of SARS-CoV-2 calls into question the practicality of a vaccine-only public-health strategy for managing the ongoing COVID-19 pandemic. It has been suggested that widespread vaccination is necessar
Externí odkaz:
https://doaj.org/article/5048dcbdf80f4d8d9efcb34df73c9033
Autor:
Debra Van Egeren, Madison Stoddard, Alexander Novokhodko, Michael S Rogers, Diane Joseph-McCarthy, Bruce Zetter, Arijit Chakravarty
Publikováno v:
PLoS ONE, Vol 16, Iss 11, p e0258997 (2021)
The development and deployment of several SARS-CoV-2 vaccines in a little over a year is an unprecedented achievement of modern medicine. The high levels of efficacy against transmission for some of these vaccines makes it feasible to use them to sup
Externí odkaz:
https://doaj.org/article/e511335d15b14ea08376aac679b5be1b
Publikováno v:
Cancer Medicine, Vol 8, Iss 12, Pp 5574-5576 (2019)
Abstract Numerous publications have stated that metastases are responsible for 90% of cancer deaths, but data underlying this assertion has been lacking. Our objective was to determine what proportions of cancer deaths are caused by metastases. Popul
Externí odkaz:
https://doaj.org/article/1b0c7d7d19704d2ab950c859f7ad1222
Autor:
Madison Stoddard, Alexander Novokhodko, Sharanya Sarkar, Debra Van Egeren, Laura F. White, Natasha S. Hochberg, Michael S. Rogers, Bruce Zetter, Diane Joseph-McCarthy, Arijit Chakravarty
Publikováno v:
COVID; Volume 2; Issue 12; Pages: 1689-1709
We have entered a new phase of the ongoing COVID-19 pandemic, as the strategy of relying solely on the current SARS-CoV-2 vaccines to bring the pandemic to an end has become infeasible. In response, public-health authorities in many countries have ad
Autor:
Aram Ghalali, Liangzhe Wang, Konrad H. Stopsack, James M. Rice, Shulin Wu, Chin-Lee Wu, Bruce R. Zetter, Michael S. Rogers
Publikováno v:
Experimental & Molecular Medicine. 54:1713-1726
The transcript encoding Antizyme Inhibitor 1 (AZIN1) is frequently edited in various cancers, and this editing is associated with enhanced tumor aggressiveness. After comparison of wild-type AZIN1 (wtAZIN1) and edited AZIN1 (edAZIN1, which contains a
Autor:
George N. Naumov, Judah Folkman, Randolph S. Watnick, Lars A. Akslen, Oddbjorn Straume, Karl-Henning Kalland, Kamila Naxerova, Soo-Young Kang, Michael Lampa, Elise R. Bender, Anne M. Oyan, Trond H. Bø, Eugene Lifshits, Anna Blois, Lorna M. Cryan, David Zurakowski, Katherine Novak, Michael S. Rogers
PDF - 120K, Supplementary Methods and legends for Supplementary Figures 1 through 3.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1d39b13f33c4d104b3ddc250bb8dbe25
https://doi.org/10.1158/1541-7786.22511149
https://doi.org/10.1158/1541-7786.22511149
Autor:
George N. Naumov, Judah Folkman, Randolph S. Watnick, Lars A. Akslen, Oddbjorn Straume, Karl-Henning Kalland, Kamila Naxerova, Soo-Young Kang, Michael Lampa, Elise R. Bender, Anne M. Oyan, Trond H. Bø, Eugene Lifshits, Anna Blois, Lorna M. Cryan, David Zurakowski, Katherine Novak, Michael S. Rogers
PDF - 254K, Supplemental Figure 1: In vivo proliferation of angiogenic and non-angiogenic cell clones. Supplemental Figure 2: Chromosomal locations of genes with relative overexpression in either angiogenic or revertant clones. Supplemental Figure 3:
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4c2840e66b0b57dfe1809c6a721fb80d
https://doi.org/10.1158/1541-7786.22511152
https://doi.org/10.1158/1541-7786.22511152
Autor:
Lorna M. Cryan, Tsz-Ming Tsang, Jessica Stiles, Lauren Bazinet, Sai Lun Lee, Samuel Garrard, Erika Madrian, Cody Roberts, Jessie Payne, Andrew Jensen, Arthur E. Frankel, P. Christine Ackroyd, Kenneth A. Christensen, Michael S. Rogers
Publikováno v:
Angiogenesis. 25:397-410
Anthrax protective antigen (PA) is a potent inhibitor of pathological angiogenesis with an unknown mechanism. In anthrax intoxication, PA interacts with capillary morphogenesis gene 2 (CMG2) and tumor endothelial marker 8 (TEM8). Here, we show that C